)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Cumberland Pharmaceuticals (CPIX) investor relations material
Cumberland Pharmaceuticals Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary5 Aug, 2025
Executive summary
Achieved 23% year-to-date revenue growth, with $22.6M in H1 2025 and a 10% Q2 increase to $10.8M, driven by Sancuso, Vibativ, Caldolor, and Acetadote.
Net income for H1 2025 was $0.5M, a turnaround from a $3.0M loss in the prior year; adjusted H1 earnings were $2.8M or $0.18/share.
Advanced clinical programs, including positive Phase II results for ifetroban in Duchenne muscular dystrophy and ongoing studies in systemic sclerosis and idiopathic pulmonary fibrosis.
International expansion included Vibativ regulatory approval in China, launches in the Middle East and Saudi Arabia, and new partnerships.
Key product launches and partnerships, including Vizient supply agreement and AI-enhanced IPF trial analytics.
Financial highlights
Q2 2025 revenues reached $10.8M, up 10% year-over-year; H1 2025 revenues totaled $22.6M, up 23%.
Adjusted H1 2025 earnings were $2.8M ($0.18/share); Q2 adjusted earnings were $400K.
Net loss for Q2 was $700K; H1 net income was $500K.
Cash and cash equivalents at June 30, 2025: $16.1M; cash flow from operations was $4.7M in H1 2025.
Working capital improved to $7.2M with a current ratio of 1.3.
Outlook and guidance
Management anticipates continued momentum from approved brands, international partnerships, and clinical pipeline progress.
Expects to announce top-line results from systemic sclerosis study later in 2025.
Ongoing focus on expanding product portfolio and leveraging infrastructure for growth.
Ongoing Phase II clinical programs for ifetroban in multiple indications, with regulatory submissions underway.
What is the expected timeline for Vibativ launch in China?
Discuss the potential impact of Vizient agreement.
When will top-line scleroderma study results be released?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cumberland Pharmaceuticals earnings date
Q3 20254 Nov, 2025
Next Cumberland Pharmaceuticals earnings date
Q3 20254 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development, acquisition, and commercialization of prescription medicines. The company's portfolio includes products for hospital acute care, gastroenterology, and rheumatology, addressing the needs of patients in critical care settings. Cumberland Pharmaceuticals is involved in all aspects of the product lifecycle, from clinical research to regulatory approval and distribution. Its target markets include healthcare providers, hospitals, and outpatient facilities across the United States. The company is headquartered in Nashville, Tennessee, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage